B |
2020-10-22 12:27:57.0 |
Celldex Therapeutics |
CLDX |
Logos Global Management LP |
4.3% |
view |
B |
2020-07-24 16:05:40.0 |
Celldex Therapeutics |
CLDX |
ADAGE CAPITAL PARTNERS GP |
5.01% |
view |
S |
2020-06-26 17:28:16.0 |
Celldex Therapeutics |
CLDX |
BIOTECHNOLOGY VALUE FUND L P |
7.2% |
view |
B |
2020-06-19 10:36:46.0 |
Celldex Therapeutics |
CLDX |
RTW INVESTMENTS |
9.95% |
view |
B |
2020-06-18 09:11:33.0 |
Celldex Therapeutics |
CLDX |
Ikarian Capital |
7.1% |
view |
B |
2020-02-12 15:57:00.0 |
Celldex Therapeutics |
CLDX |
RENAISSANCE TECHNOLOGIES LLC |
6.91% |
view |
S |
2019-02-11 09:14:47.0 |
Celldex Therapeutics |
CLDX |
VANGUARD GROUP INC |
3.63% |
view |
S |
2018-07-10 08:26:58.0 |
Celldex Therapeutics |
CLDX |
BlackRock Inc |
2.5% |
view |
S |
2018-05-10 10:50:10.0 |
Celldex Therapeutics |
CLDX |
FMR LLC |
n/a |
view |
B |
2018-02-13 10:06:03.0 |
Celldex Therapeutics |
CLDX |
COLUMBIA WANGER ASSET MANAGEMENT LLC |
7.9% |
view |
S |
2018-02-13 09:35:12.0 |
Celldex Therapeutics |
CLDX |
FMR LLC |
5.607% |
view |
S |
2018-02-08 17:41:44.0 |
Celldex Therapeutics |
CLDX |
VANGUARD GROUP INC |
6.27% |
view |
S |
2018-02-06 11:43:43.0 |
Celldex Therapeutics |
CLDX |
FRANKLIN RESOURCES INC |
0.0% |
view |
S |
2018-01-29 16:39:59.0 |
Celldex Therapeutics |
CLDX |
BlackRock Inc |
7.3% |
view |
S |
2017-12-11 10:37:38.0 |
Celldex Therapeutics |
CLDX |
FMR LLC |
5.725% |
view |
S |
2017-05-10 09:52:01.0 |
Celldex Therapeutics |
CLDX |
FMR LLC |
10.951% |
view |
S |
2017-02-14 13:05:32.0 |
Celldex Therapeutics |
CLDX |
OppenheimerFunds |
0.0% |
view |
B |
2017-02-14 10:55:39.0 |
Celldex Therapeutics |
CLDX |
FMR LLC |
16.174% |
view |
B |
2017-02-10 09:40:55.0 |
Celldex Therapeutics |
CLDX |
COLUMBIA WANGER ASSET MANAGEMENT LLC |
5.1% |
view |
S |
2017-02-10 08:09:07.0 |
Celldex Therapeutics |
CLDX |
VANGUARD GROUP INC |
6.51% |
view |
S |
2017-02-10 06:18:45.0 |
Celldex Therapeutics |
CLDX |
STATE STREET CORP |
3.62% |
view |
S |
2017-02-09 13:58:18.0 |
Celldex Therapeutics |
CLDX |
FRANKLIN RESOURCES INC |
5.2% |
view |
S |
2017-01-31 10:47:00.0 |
Celldex Therapeutics |
CLDX |
FIRST TRUST PORTFOLIOS LP |
0.0% |
view |
B |
2017-01-23 14:17:17.0 |
Celldex Therapeutics |
CLDX |
BlackRock Inc |
7.8% |
view |
B |
2016-12-09 11:57:32.0 |
Celldex Therapeutics |
CLDX |
KLP Enterprises |
5.7% |
view |
B |
2016-04-08 14:00:55.0 |
Celldex Therapeutics |
CLDX |
STATE STREET CORP |
8.67% |
view |
B |
2016-02-12 09:01:29.0 |
Celldex Therapeutics |
CLDX |
FMR LLC |
14.999% |
view |
B |
2016-02-10 14:20:35.0 |
Celldex Therapeutics |
CLDX |
VANGUARD GROUP INC |
6.88% |
view |
S |
2016-02-04 13:23:19.0 |
Celldex Therapeutics |
CLDX |
FRANKLIN RESOURCES INC |
9.9% |
view |
B |
2016-02-02 10:33:27.0 |
Celldex Therapeutics |
CLDX |
OppenheimerFunds |
9.02% |
view |
B |
2016-01-27 09:49:17.0 |
Celldex Therapeutics |
CLDX |
FIRST TRUST PORTFOLIOS LP |
7.53% |
view |
S |
2016-01-26 08:19:19.0 |
Celldex Therapeutics |
CLDX |
BlackRock Inc |
6.6% |
view |
B |
2015-02-13 10:06:47.0 |
Celldex Therapeutics |
CLDX |
FMR LLC |
14.999% |
view |
B |
2015-02-10 15:47:02.0 |
Celldex Therapeutics |
CLDX |
VANGUARD GROUP INC |
6.03% |
view |
S |
2015-02-06 19:20:33.0 |
Celldex Therapeutics |
CLDX |
FRANKLIN RESOURCES INC |
10.7% |
view |
B |
2015-01-29 14:20:24.0 |
Celldex Therapeutics |
CLDX |
BlackRock Inc |
7.0% |
view |
B |
2014-04-10 14:56:56.0 |
Celldex Therapeutics |
CLDX |
FRANKLIN RESOURCES INC |
11.1% |
view |
S |
2014-02-14 14:36:07.0 |
Celldex Therapeutics |
CLDX |
SAC Capital Advisors LP |
4.0% |
view |
B |
2014-02-14 06:47:31.0 |
Celldex Therapeutics |
CLDX |
FMR LLC |
13.672% |
view |
B |
2014-02-12 10:04:46.0 |
Celldex Therapeutics |
CLDX |
VANGUARD GROUP INC |
5.59% |
view |
B |
2014-02-10 18:37:52.0 |
Celldex Therapeutics |
CLDX |
FRANKLIN RESOURCES INC |
9.0% |
view |
S |
2014-02-07 13:21:37.0 |
Celldex Therapeutics |
CLDX |
PRUDENTIAL FINANCIAL INC |
n/a |
view |
S |
2014-02-06 16:48:22.0 |
Celldex Therapeutics |
CLDX |
JENNISON ASSOCIATES LLC |
4.5% |
view |
S |
2014-02-06 16:47:38.0 |
Celldex Therapeutics |
CLDX |
JENNISON ASSOCIATES LLC |
4.5% |
view |
S |
2014-01-28 15:23:02.0 |
Celldex Therapeutics |
CLDX |
BlackRock Inc |
6.7% |
view |
B |
2013-09-10 09:46:49.0 |
Celldex Therapeutics |
CLDX |
FMR LLC |
10.21% |
view |
B |
2013-04-22 16:15:45.0 |
Celldex Therapeutics |
CLDX |
SAC Capital Advisors LP |
5.4% |
view |
B |
2013-04-05 16:57:40.0 |
Celldex Therapeutics |
CLDX |
SAC Capital Advisors LP |
4.9% |
view |
B |
2013-02-13 15:17:14.0 |
Celldex Therapeutics |
CLDX |
PRUDENTIAL FINANCIAL INC |
5.9% |
view |
B |
2013-02-11 16:11:01.0 |
Celldex Therapeutics |
CLDX |
JENNISON ASSOCIATES LLC |
5.7% |
view |
B |
2013-01-30 14:29:58.0 |
Celldex Therapeutics |
CLDX |
BlackRock Inc |
8.65% |
view |
B |
2012-12-28 16:44:32.0 |
Celldex Therapeutics |
CLDX |
Ridgeback Capital Investments L |
6.1% |
view |
S |
2012-03-09 17:32:45.0 |
Celldex Therapeutics |
CLDX |
BlackRock Inc |
4.79% |
view |
B |
2012-02-13 11:50:10.0 |
Celldex Therapeutics |
CLDX |
BlackRock Inc |
6.26% |
view |
B |
2011-05-26 16:44:21.0 |
Celldex Therapeutics |
CLDX |
HealthCor Management |
5.86% |
view |
B |
2011-02-03 09:08:47.0 |
Celldex Therapeutics |
CLDX |
BlackRock Inc |
5.89% |
view |
S |
2009-12-23 16:37:34.0 |
Celldex Therapeutics |
CLDX |
BRISTOL MYERS SQUIBB CO |
4.71% |
view |
S |
2009-12-15 17:13:20.0 |
Celldex Therapeutics |
CLDX |
BRISTOL MYERS SQUIBB CO |
5.99% |
view |
S |
2009-12-09 17:23:33.0 |
Celldex Therapeutics |
CLDX |
BRISTOL MYERS SQUIBB CO |
7.83% |
view |
B |
2009-11-25 16:58:57.0 |
Celldex Therapeutics |
CLDX |
BRISTOL MYERS SQUIBB CO |
9.14% |
view |
S |
2009-06-26 17:09:56.0 |
Celldex Therapeutics |
CLDX |
MEDAREX INC |
18.7% |
view |
B |
2009-05-27 10:58:37.0 |
Celldex Therapeutics |
CLDX |
APAX PARTNERS EUROPE MANAGERS LTD |
8.75% |
view |
S |
2009-02-12 12:23:35.0 |
Celldex Therapeutics |
CLDX |
FGS ADVISORS LLC |
0.0% |
view |
S |
2008-06-26 16:46:29.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
MEDAREX INC |
31.6% |
view |
S |
2008-05-12 16:50:28.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
Lorantis Holdings LTD |
n/a |
view |
S |
2008-04-03 16:26:28.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
Paluck Thomas S |
4.6% |
view |
B |
2008-03-25 16:09:41.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
Lorantis Holdings LTD |
18.8% |
view |
B |
2008-03-17 17:17:19.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
MEDAREX INC |
35.6% |
view |
S |
2008-02-27 18:39:10.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
TSP Capital Management Group |
0.0% |
view |
B |
2008-02-27 18:31:17.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
Paluck Thomas S |
10.3% |
view |
B |
2008-02-27 18:27:47.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
Paluck Thomas S |
5.3% |
view |
B |
2008-02-27 18:24:15.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
Paluck Thomas S |
5.2% |
view |
B |
2008-02-13 16:46:42.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
FGS ADVISORS LLC |
5.7% |
view |
B |
2008-01-29 17:57:56.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
BIOTECHNOLOGY VALUE FUND L P |
18.733% |
view |
B |
2008-01-16 10:16:15.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
TSP Capital Management Group |
10.06% |
view |
B |
2006-03-30 00:00:00.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
FGS ADVISORS LLC |
5.15% |
view |
S |
2006-02-10 00:00:00.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
BIOTECHNOLOGY VALUE FUND L P |
3.0% |
view |
B |
2005-07-07 00:00:00.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
BIOTECHNOLOGY VALUE FUND L P |
5.1% |
view |
S |
2004-02-18 00:00:00.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
MILLENNIUM PARTNERS L P |
4.26% |
view |
B |
2003-07-10 00:00:00.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
MILLENNIUM PARTNERS L P |
7.48% |
view |
S |
2003-02-14 00:00:00.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
FORSTMANN LEFF ASSOCIATES LLC |
0.0% |
view |
B |
2002-02-14 00:00:00.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
FORSTMANN LEFF ASSOCIATES LLC |
6.8% |
view |
S |
2002-02-11 00:00:00.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
HEALTHCARE VENTURES II LP |
4.57% |
view |
S |
2002-02-01 00:00:00.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
DRESDNER RCM GLOBAL INVESTORS LLC |
1.81% |
view |
B |
2001-02-07 00:00:00.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
DRESDNER RCM GLOBAL INVESTORS LLC |
6.02% |
view |
S |
2001-02-07 00:00:00.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
HEALTHCARE VENTURES II LP |
5.04% |
view |
S |
2000-04-12 00:00:00.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
FOREST CITY ENTERPRISES INC |
2.87% |
view |
B |
1999-10-01 00:00:00.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
NOMURA INTERNATIONAL PLC |
5.4% |
view |
S |
1999-02-16 00:00:00.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
HEALTHCARE VENTURES II LP |
11.5% |
view |
S |
1999-02-11 00:00:00.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
CAPITAL RESEARCH & MANAGEMENT CO |
0.0% |
view |
B |
1998-09-01 00:00:00.0 |
AVANT IMMUNOTHERAPEUTICS INC |
AVAN |
HEALTHCARE VENTURES II LP |
11.7% |
view |
S |
1998-07-23 00:00:00.0 |
T CELL SCIENCES INC |
AVAN |
FOREST CITY ENTERPRISES INC |
5.1% |
view |
S |
1998-07-09 00:00:00.0 |
T CELL SCIENCES INC |
AVAN |
CAPITAL GROUP COMPANIES INC ET AL |
0.0% |
view |
S |
1998-07-09 00:00:00.0 |
T CELL SCIENCES INC |
AVAN |
CAPITAL GROUP COMPANIES INC ET AL |
5.2% |
view |
B |
1998-07-09 00:00:00.0 |
T CELL SCIENCES INC |
AVAN |
CAPITAL RESEARCH & MANAGEMENT CO |
5.2% |
view |
B |
1998-02-11 00:00:00.0 |
T CELL SCIENCES INC |
AVAN |
CAPITAL GROUP COMPANIES INC ET AL |
5.2% |
view |
B |
1997-11-25 00:00:00.0 |
T CELL SCIENCES INC |
AVAN |
FOREST CITY ENTERPRISES INC |
5.67% |
view |